IMM 1.56% 31.5¢ immutep limited

Overnight Market report, page-1663

  1. 2,635 Posts.
    lightbulb Created with Sketch. 326

    Hey Mega
    “The company notes that, importantly, it will now have access to more frequent meetings and communications with the FDA. It could potentially even receive Rolling Review of its Biologic License Application (once submitted) and may be eligible for Accelerated Approval and Priority Review, if relevant criteria are met.”


 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.